⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Hedera Dx and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Hedera Dx
↗Epalinges, Switzerland
Hedera Dx is a Swiss techbio company dedicated to transforming oncology care by enabling hospital laboratories to perform sophisticated, in-house molecular diagnostics. The company provides a decentralized liquid biopsy solution that combines laboratory assays with an AI-native software platform (Hedera Prime) to streamline tumor profiling and improve patient access to targeted therapies.
Beyond diagnostics, Hedera Dx leverages its decentralized network to aggregate high-quality, longitudinal real-world data (RWD). This data infrastructure supports pharmaceutical and biotech companies in biomarker discovery, clinical trial optimization, and the development of next-generation personalized cancer therapies.
CLASSIFICATION
SIZE & FINANCIALS
Employees:1-50
Founded:2021
Ownership:private
Status:operating
FUNDING
Stage:Series A
Total Raised:$31.6M
Investors:Vsquared Ventures, Tesi, Helsana HealthInvest, Eyrir Venture Management, Inventure, Top Harvest Capital, Air Street Capital, Amino Collective, GRIDS Capital, TA Ventures, ReykVC
PIPELINE
Stage:Commercial
Lead Drug Stage:N/A (Diagnostic/Techbio platform)
Modalities:Liquid Biopsy, NGS (Next-Generation Sequencing)
Active Trials:1
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Leading cancer centers (e.g., Technical University of Munich/TUM), Pharmaceutical companies (collaborations for clinical trial testing and RWE)
COMPETITION
Position:Emerging
LEADERSHIP
Key Executives:
Tommi Lehtonen - CEO and Co-founder
Christian Meisel - CMO and Co-founder
Damien Lapray - CCO and Co-founder
Scientific Founders:Tommi Lehtonen, Damien Lapray, Christian Meisel
LINKS
Website:hederadx.com
LinkedIn:LinkedIn Profile
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Hedera Dx. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.